Measures leptin, a hormone involved in regulating appetite and metabolism. Suits people wanting to check whether leptin levels could be a factor in difficulty managing hunger or weight.
1 biomarker as listed by Medichecks.
This test measures leptin, a hormone produced by fat tissue that helps regulate appetite and how the body uses energy. Leptin is commonly discussed in the context of leptin resistance, where the body responds less well to the hormone's signals, and testing it can be one part of a wider assessment of hunger, weight and energy regulation, alongside other factors your GP or a specialist may want to consider.
There are no comparable tests in our data for this panel, and the fact sheet notes there is currently nothing to benchmark the £150 price against. This means we cannot say how it compares on cost with other single-hormone tests on the market.
The scores reflect a narrow, single-marker test. Clinical depth scores low, in the bottom few percent of metabolism tests we track, since it measures only one marker. Trust signals score highly, based on Medichecks' Trustpilot record, its UKAS ISO 15189 partner labs and doctor review as standard, and results and follow-up benefit from every result being reviewed by a doctor.
This suits people who, with their GP or a specialist, want to check leptin specifically as part of a wider conversation about hunger, weight or energy regulation. It is not a general weight-management or metabolic panel on its own.
We do not have comparable tests in our data for this panel, so we cannot point you to a cheaper or broader alternative here. If weight changes are unexplained or came on rapidly, speak to your GP rather than relying on a single hormone result.
Samples are collected by venous blood draw at a clinic, or you can arrange a home nurse visit; there is no at-home finger-prick option for this test. Once the sample reaches the lab, results are typically ready within eight days, and every result is reviewed by a doctor as standard.
Leptin, a hormone involved in regulating appetite and metabolism, is the sole marker in this £150 test. There are no comparable tests in our data to benchmark the price against, so we cannot say whether it is cheap or expensive relative to peers. Clinical depth is limited, since it is a one-marker test, though every result is reviewed by a doctor.
The listing publishes a short description, the full biomarker list, a stated turnaround, clear collection options, the sample type; it does not state what the report looks like.
1 biomarkers, placing it in the 3rd percentile of metabolism tests we track.
A blood sample taken at home by a visiting nurse or phlebotomist; with a venous or clinic option as well; a home nurse visit is offered; results in around 8 days, slower than similar tests.
Results are reviewed by a doctor; the provider does not describe the report format.
Trustpilot 4.5 from 2,477 reviews; accredited lab (UKAS ISO 15189 partner labs); doctor review as standard; trading 25+ years.
£150.00; no comparable tests to benchmark against yet.
Calculated 13 September 2026 from the facts we hold about this test and provider, using our published scoring formula. Scores are not hand-edited.
Mid-depth metabolic panel priced well below peers
Measures 19 markers of blood sugar, cholesterol, liver, kidney and inflammation to give a broad view of metabolic health.
Below-median price for a single-marker uric acid test
A single-marker blood test measuring uric acid, used to help monitor gout risk and related joint, kidney and metabolic health.
Organ and metabolic monitoring panel for Ozempic users
This 21-marker panel checks liver, kidney, lipid and blood sugar markers alongside lipase, designed for people taking Ozempic (semaglutide) who want to monitor how their body is responding to treatment.
Wide 21-marker panel for ongoing Wegovy monitoring
This is a 21-marker blood panel covering kidney, liver, lipid and blood sugar markers, intended for people taking Wegovy (semaglutide) for weight management who want to monitor these systems over time. It suits ongoing monitoring rather than one-off screening.
